Loading...
Updated NCCN Guidelines Will Expand Rare Disease Diagnosis
AN
AnalystConsensusTarget
Not Invested
Based on Analyst Price Targets
Published
10 Sep 24
Updated
30 Apr 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
6.9%7D
0.5%1Y
6.9%7D
0.5%You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.